Global /Taiwan /Healthcare /Medical Devices /6645

Kim Forest Enterprise Co., Ltd.

6645

• TWSE: 6645 • Delayed

12.90TWD -1.2%

0.4083 USD

As of 6 June 2026, Kim Forest Enterprise Co., Ltd. has a market cap of $25.15M USD, ranking #35475 globally and #2175 in Taiwan. It ranks #3203 in the Healthcare sector, and #681 in the Medical Devices industry.

Global Rank

35475

Country Rank

2175

Sector Rank

3203

Industry Rank

681

Key Stats

Market Cap

$25.15MUSD

791.14M TWD

Enterprise Value

$33.97MUSD

1.07B TWD

Revenue (TTM)

$17.46MUSD

549.14M TWD

EBITDA (TTM)

-$3.06MUSD

-96.6M TWD

Net Income (TTM)

-$4.66MUSD

-146.45M TWD

EBITDA Margin

-18%

Profit Margin

-27%

PS Ratio

1.4

PB Ratio

1.5

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Medical Devices

CEO

Daniel Huang open_in_new

Employees

Founded

2004

Website

kimforest.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.2%	-2.6%	-4.4%	-27%	-40%	-26%	-38%	-55%	-36%

News

Markets

Exchange	Ticker	Price	Quotes
Taiwan Stock Exchange (TWSE) MIC: XTAI PRIMARY	6645 金萬林企業股份有限公司 ISIN: TW0006645005 Shares Out.: Shares Outstanding: 60.624M¹ TV: TradingView: TWSE: 6645 SA: Stock Analysis: TPE: 6645 YF: Yahoo Finance: 6645.TW GF: Google Finance: TPE: 6645 BA: Barron's: 6645 MS: Morningstar: XTAI: 6645	12.90 TWD	TV: TradingView: TWSE: 6645 SA: Stock Analysis: TPE: 6645 YF: Yahoo Finance: 6645.TW GF: Google Finance: TPE: 6645 BA: Barron's: 6645 MS: Morningstar: XTAI: 6645

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Kim Forest Enterprise Co., Ltd.

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in the wholesale of medical instruments and consumables; and provision of various genetic and medical testing services. The company was founded in 2004 and is headquartered in New Taipei City, Taiwan.

Similar Companies

Industry: Medical Devices (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Sunmax Biotechnology Co., Ltd. TPEX: 4728	$670.9M 21.1B TWD 3K%	29.1	Taiwan
TaiDoc Technology Corp. TWSE: 4736	$378.99M 11.92B TWD 1K%	8.3	Taiwan
YD Bio Ltd. NASDAQ: YDES	$364.92M 1K%	-	Taiwan
United Orthopedic Corp. TPEX: 4129	$303.5M 9.55B TWD 1K%	17.5	Taiwan
Bioteque Corp. TPEX: 4107	$255.54M 8.04B TWD 916%	15.0	Taiwan
Hi-Clearance Inc. TPEX: 1788	$191.77M 6.03B TWD 663%	16.4	Taiwan

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 689K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 639K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 632K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 503K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 480K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 405K%	22.2	Ireland

chevron_leftBack